Dave Reisinger
Analyst
Analyst — Leerink Partners
Earnings-call appearances
-
Halozyme to Report Second Quarter 2026 Financial and Operating Results2026-08-06
Halozyme Therapeutics, Inc. (HALO)
-
Immunovant, Inc. Q3 FY2026 Earnings Call2026-02-06
Immunovant, Inc. (IMVT)